- NEWS
Results suggest that vaccines offer less protection against lingering symptoms than expected.
By
-
Sara Reardon
-
Sara Reardon is a freelance science journalist based in Bozeman, Montana.
-
Vaccination against SARS-CoV-2 lowers the risk of long COVID after infection by only about 15%, according to a study of more than 13 million people1. That’s the largest cohort that has yet been used to examine how much vaccines protect against the condition, but it is unlikely to end the uncertainty.
doi: https://doi.org/10.1038/d41586-022-01453-0
References
Al-Aly, Z., Bowe, B. & Xie, Y. Nature Med. https://doi.org/10.1038/s41591-022-01840-0 (2022).
Yoo, S. M. et al. J. Gen. Intern. Med. https://doi.org/10.1007/s11606-022-07523-3 (2022).
Stephenson, T. et al. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-798316/v1 (2021).
Xie, Y., Bowe, B. & Al-Aly, Z. Nature Commun. 12, 6571 (2021).
Antonelli, M. et al. Lancet. Infect. Dis. 22, 43–55 (2022).
Related Articles
-
Can drugs reduce the risk of long COVID? What scientists know so far
-
Heart-disease risk soars after COVID — even with a mild case
-
Pandemics disable people — the history lesson that policymakers ignore
Coronavirus ‘ghosts’ found lingering in the gut